Shore Capital Group Reiterates Hold Rating for CVS Group (LON:CVSG)

CVS Group (LON:CVSG)‘s stock had its “hold” rating reiterated by analysts at Shore Capital Group in a note issued to investors on Thursday, London Stock Exchange reports. They presently have a GBX 1,400 price target on the stock. Shore Capital Group’s price target indicates a potential upside of 14.19% from the company’s current price.

A number of other analysts have also recently weighed in on CVSG. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 1,700 price target on shares of CVS Group in a research note on Monday, July 27th. Jefferies Financial Group upped their target price on shares of CVS Group from GBX 1,350 to GBX 1,400 and gave the company a “hold” rating in a report on Friday, July 31st. Finally, Berenberg Bank reiterated a “buy” rating and set a GBX 2,000 target price on shares of CVS Group in a research note on Thursday. Four equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of GBX 1,666.67.

CVS Group Price Performance

Shares of LON CVSG opened at GBX 1,226 on Thursday. The company has a current ratio of 1.07, a quick ratio of 0.90 and a debt-to-equity ratio of 92.34. CVS Group has a twelve month low of GBX 1,062 and a twelve month high of GBX 1,648. The stock has a 50 day moving average of GBX 1,289.88 and a two-hundred day moving average of GBX 1,230. The stock has a market cap of £833.31 million, a P/E ratio of 17.79, a P/E/G ratio of 1.77 and a beta of 1.07.

CVS Group (LON:CVSG) last announced its earnings results on Thursday, September 24th. The company reported GBX 85.60 earnings per share (EPS) for the quarter. CVS Group had a net margin of 2.31% and a return on equity of 5.35%. On average, research analysts forecast that CVS Group will post 93.9393939 earnings per share for the current year.

Insider Transactions at CVS Group

In other news, insider Robin Alfonso acquired 768 shares of the stock in a transaction that occurred on Thursday, August 6th. The shares were purchased at an average cost of GBX 1,294 per share, for a total transaction of £9,937.92. Also, insider Joanne Shaw acquired 1,592 shares of the company’s stock in a transaction on Monday, August 10th. The stock was purchased at an average cost of GBX 1,287 per share, for a total transaction of £20,489.04. Insiders purchased 3,860 shares of company stock worth $4,956,696 over the last 90 days. 1.48% of the stock is currently owned by insiders.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.